Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research

Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

Please add ResearchGrants@BrightFocus.org to your institution’s white list to insure that the notification is not blocked by your organization’s SPAM filters.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research


National Glaucoma Research
Current Award

Dr. Yiqin Du

Yiqin Du, MD, PhD

Pittsburgh, PA
University of Pittsburgh

Title: A Mouse Glaucoma Model and Cell Therapy for Glaucoma
Non-Technical Title: Cell Therapy in A Mouse Model with Increased Eye Pressure

Acknowledgements: This grant is made possible in part by a bequest from the estate of June Mae Metzger.
Duration: July 1, 2014 - June 30, 2016
Award Type: Standard
Award Amount: $100,000


Glaucoma is a leading cause of irreversible blindness. Elevated intraocular pressure (IOP) is a major risk factor for glaucoma, and it is controllable. The trabecular meshwork (TM), spongy issue near the surface of the eyeball, acts as a drainage system for the aqueous humor, a transparent, gelatinous fluid that fills the space between the lens and the cornea of the eye and nourishes the lens. When this TM drainage system becomes blocked, as can happen from irregularities in the cells and matrix of the meshwork, the blockage can lead to a build-up of aqueous fluid in the eye and subsequent elevation of IOP. We have isolated and characterized immature cells from the TM with the ability to seek out and repair the damage in this tissue. Our research will consist of modelling elevated pressure by damaging the TM in a mouse model and then attempting to rebuild and restore a functioning meshwork and reduce the intraocular pressure with cell therapy using immature TM cells.


Glaucoma is generally recognized as a group of diseases that increase pressure in the eye through a malfunctioning of the trabecular meshwork (TM), which is an outflow track that maintains regular pressure in a healthy eye. Dr. Du and colleagues are developing and characterizing a mouse glaucoma model by inducing endoplastic reticulum stress in the trabecular meshwork. The team has identified a cell population from the TM and will apply these cells to the mouse model to investigate cell-based therapies for glaucoma and prevention of glaucomatous blindness.

Details. It has been suggested that age- and disease-related decreases of TM cellularity and accelerated apoptosis and senescence of the cells are associated with glaucoma. Increased endoplastic reticulum stress in the TM has been reported to cause intraocular pressure elevation. Dr. Du and colleagues are testing the different effects of several endoplastic reticulum stress inducers on cultured TM cells and extracellular matrix the cells secrete. The team will treat mice with the endoplastic reticulum stress inducers and characterize their effects on the corneal endothelium, TM, outflow facility, intraocular pressure and optic nerve damage by elevated pressure. They will optimize the delivery system and dosage. When the mouse model has been developed and characterized, the team will apply TM cells to the mouse model and investigate their ability of to remodel the structure of the outflow tract, decrease intraocular pressure and prevent optic nerve damage.

When this study is complete, Dr. Du and colleagues will have developed a mouse model that will elucidate the relationship between TM cellularity and intraocular pressure elevation. Their study will direct the development of cell-based therapies for glaucoma, which will lead to a revolutionary advance in treatment for glaucoma.

Investigator Biography:

Yiqin Du is an assistant professor of ophthalmology and developmental biology at the University of Pittsburgh. She received her M. and PhD degrees in China and completed her postdoctoral training at Beijing University and the University of Pittsburgh. Dr. Du practiced as an ophthalmologist in China for more than 10 years and also has been studying cell-based therapies for eye diseases. Her laboratory focuses on cell biology, understanding the cellular and molecular mechanisms of glaucoma and developing new therapies for glaucoma.